Sangamo BioSciences | SGMO - Ebit

Aktienkurs
0.25
Täglich Wechseln
-0.01 -4.09%
Monatlich
-38.64%
Jährlich
-65.04%
Q2 Prognose
0.24




Ebit Veränderung Datum
Alaunos Therapeutics USD -1.19M 148K 2025-09
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
Amgen USD 3.96B 464M 2025-12
Bayer EUR 1.11B 1.51B 2025-12
BioCryst Pharmaceuticals USD 260.38M 230.79M 2025-12
Biogen USD 659.6M 157M 2025-09
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Cipla INR 9.77B 6.21B 2025-12
Clal Biotechnology ILS -5.44M 3.76M 2022-12
Compugen USD 56.04M 63.94M 2025-12
CSL USD 2.64B 116M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Grifols EUR 320.55M 91.01M 2025-12
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
J&J USD 5.11B 2.3B 2025-12
Karyopharm Therapeutics USD -17.84M 8.44M 2025-12
Merck USD 6.24B 1.32B 2025-12
Novartis USD 4.06B 530M 2025-12
Omeros USD -48.15M 7.25M 2023-09
Pfizer USD 4.65B 71M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
Tectonic Therapeutic USD -21.52M 374K 2025-12
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12